- Home
- NKSH vs HRTX Comparison
NKSH vs HRTX Comparison
Compare NKSH & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- HRTX
- Stock Information
- Founded
- NKSH 1891
- HRTX 1983
- Country
- NKSH United States
- HRTX United States
- Employees
- NKSH N/A
- HRTX N/A
- Industry
- NKSH Major Banks
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- NKSH Finance
- HRTX Health Care
- Exchange
- NKSH Nasdaq
- HRTX Nasdaq
- Market Cap
- NKSH 172.6M
- HRTX 206.9M
- IPO Year
- NKSH N/A
- HRTX 1987
- Fundamental
- Price
- NKSH $31.30
- HRTX $1.30
- Analyst Decision
- NKSH Strong Buy
- HRTX Strong Buy
- Analyst Count
- NKSH 1
- HRTX 2
- Target Price
- NKSH $38.00
- HRTX $4.50
- AVG Volume (30 Days)
- NKSH 10.8K
- HRTX 1.9M
- Earning Date
- NKSH 10-23-2025
- HRTX 08-08-2025
- Dividend Yield
- NKSH 4.85%
- HRTX N/A
- EPS Growth
- NKSH 15.57
- HRTX N/A
- EPS
- NKSH 1.77
- HRTX N/A
- Revenue
- NKSH $49,801,000.00
- HRTX $149,694,000.00
- Revenue This Year
- NKSH $2.95
- HRTX $10.62
- Revenue Next Year
- NKSH $9.97
- HRTX $12.99
- P/E Ratio
- NKSH $17.57
- HRTX N/A
- Revenue Growth
- NKSH 16.22
- HRTX 9.78
- 52 Week Low
- NKSH $23.75
- HRTX $1.04
- 52 Week High
- NKSH $32.89
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- NKSH 62.67
- HRTX 34.00
- Support Level
- NKSH $30.52
- HRTX $1.27
- Resistance Level
- NKSH $31.40
- HRTX $1.35
- Average True Range (ATR)
- NKSH 0.71
- HRTX 0.06
- MACD
- NKSH 0.08
- HRTX 0.02
- Stochastic Oscillator
- NKSH 88.51
- HRTX 27.78
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.